Back to search

Article

Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington’s disease

2022-04-22

Abstract excerpt

<h4>Background and Objectives</h4> Fluid biomarkers are a recent field of interest in Huntington disease (HD). We focused on small circulating RNAs from plasma of subjects with prodromal (pre-HD) and overt disease by a two-stage approach: an unbiased investigation by an array method and a validation study to quantify a significant small nucleolar RNA. <h4>Methods</h4> Through Affymetrix Gene-Chip-miRNA-Array we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c9a92492-112d-59be-85b5-fd962557fe24
DOI
10.1101/2022.04.22.489178
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Circulating U13 small nucleolar RNA as a candidate biomarker for Huntington’s diseaseDOI 10.1101/2022.04.22.489178
Circulating miRNA Signatures in Early-Stage Huntington’s DiseaseSemantic proximity
Small nucleolar RNAs in plasma and their discriminatory power as diagnostic biomarkers of Alzheimer’s diseaseSemantic proximity
The Emerging Role of microRNAs in Polyglutamine DiseasesSemantic proximity
MicroRNAs in CSF as prodromal biomarkers for Huntington disease in the PREDICT-HD studySemantic proximity
Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington's disease.Semantic proximity
Small RNAs in plasma extracellular vesicles define biomarkers of premanifest changes in Huntington’s diseaseSemantic proximity
Abnormal molecular signatures of inflammation, energy metabolism and vesicle biology in human Huntington disease peripheral tissuesSemantic proximity
What, When and How to Measure-Peripheral Biomarkers in Therapy of Huntington's Disease.Semantic proximity
Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood.Semantic proximity
Abnormal molecular signatures of inflammation, energy metabolism, and vesicle biology in human Huntington disease peripheral tissuesSemantic proximity
Neuron-derived extracellular vesicles in plasma present a potential non-invasive biomarker for Huntingtin protein and RNA assessment in Huntington diseaseSemantic proximity
Development of biomarkers for Huntington's diseaseSemantic proximity
Select a neighboring publication to make it the new centre.